BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8398688)

  • 1. Tumourigenesis associated with the p53 tumour suppressor gene.
    Chang F; Syrjänen S; Tervahauta A; Syrjänen K
    Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
    Stein T; Crighton D; Boyle JM; Varley JM; White RJ
    Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [P53 and cancers].
    May P; May E
    Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
    Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
    Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and human cancers.
    Lane DP
    Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the p53 tumor-suppressor gene in clinical oncology.
    Chang F; Syrjänen S; Syrjänen K
    J Clin Oncol; 1995 Apr; 13(4):1009-22. PubMed ID: 7707100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
    Wang XW; Harris CC
    Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 tumor-suppressor gene and human carcinogenesis.
    Basset-Séguin N; Molès JP; Mils V; Dereure O; Guilhou JJ
    Exp Dermatol; 1993 Jun; 2(3):99-105. PubMed ID: 8162331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
    Gu J; Kawai H; Wiederschain D; Yuan ZM
    Cancer Res; 2001 Feb; 61(4):1741-6. PubMed ID: 11245491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [p53 transgenic and knockout mice].
    Oda H
    Nihon Rinsho; 2000 Jun; 58(6):1250-4. PubMed ID: 10879049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
    Birch JM; Heighway J; Teare MD; Kelsey AM; Hartley AL; Tricker KJ; Crowther D; Lane DP; Santibáñez-Koref MF
    Br J Cancer; 1994 Dec; 70(6):1176-81. PubMed ID: 7981072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
    Adesina AM; Nalbantoglu J; Cavenee WK
    Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage, oncogenesis and the p53 tumour-suppressor gene.
    Lee JM; Abrahamson JL; Bernstein A
    Mutat Res; 1994 Jun; 307(2):573-81. PubMed ID: 7514730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transgenic mice in identification and characterization of tumour suppressor genes.
    Sharan SK; Bradley A
    Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.